ChulKimMD

Oncology • Washington, DC

Physician

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
3800 Reservoir Rd NW
Washington, DC 20007
Phone+1 202-444-2223

Fax+1 202-444-9429

Education & Training

National Institutes of Health Clinical CenterFellowship, Medical Oncology, 2014 - 2017
OtherClass of 2007
University of MinnesotaResidency, Internal Medicine

Certifications & Licensure

DC State Medical License 2017 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy Start of enrollment: 2020 Apr 16
ACTIVE_NOT_RECRUITING
PHASE2
A Study to Investigate LYL797 in Adults With Solid Tumors Start of enrollment: 2022 Mar 29
ACTIVE_NOT_RECRUITING
PHASE1
Roles: Contact
MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer Start of enrollment: 2024 Apr 15
RECRUITING
PHASE2
Roles: Principal Investigator, Contact
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors Start of enrollment: 2024 Apr 25
RECRUITING
PHASE2
Roles: Principal Investigator, Contact
A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers Start of enrollment: 2023 Apr 18
ACTIVE_NOT_RECRUITING
PHASE1
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Shared decision making in routine oncology appointments with Black patients with lung cancer.
Katarina E AuBuchon, Amanda Khoudary, Jennifer D Rodriguez, Osairys M Billini, Isabella Westervelt
Supportive Care in Cancer. 2025-03-05
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.
Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, Ryan Denu, Walid Macaron
Journal for Immunotherapy of Cancer. 2025-03-03
MAD::NUT Fusion Sarcoma: A Sarcoma Class With NUTM1, NUTM2A, and NUTM2G Fusions and Possibly Distinctive Subtypes.
David J Papke Jr, John S A Chrisinger, Christopher A French, Anthony Crymes, Thomas C Krivak
Modern Pathology. 2025-02-06

Press Mentions

Chemo-IO over IO Alone in Patients with Advanced NSCLCJuly 13th, 2021
Genomic Test in Lung Cancer: Waiting Is the Hardest PartJuly 6th, 2021
What Did We Learn from IMpower010 in Resectable NSCLC?June 22nd, 2021
Join now to see all